Review
Copyright ©The Author(s) 2017.
World J Cardiol. Jun 26, 2017; 9(6): 481-495
Published online Jun 26, 2017. doi: 10.4330/wjc.v9.i6.481
Table 1 Echocardiographic criteria for the definition of severe aortic stenosis: Advantages and disadvantages[18]
CriteriaSevere ASAdvantagesDisadvantages
Aortic surface area≤ 1.0 cm2Measures effective AVA. However, this may also constitute a disadvantage because it does not measure anatomical AVAVery sensitive to measurement errors
Less flow-dependent compared with other measurements
Indexed AVA to body surface area≤ 0.6 cm2/m2Useful for extreme heights/weightsVery sensitive to measurement errors
Mean transaortic pressure gradient≥ 40 mmHgFlow-dependent
Requires correct alignment of Doppler signal with the flow direction
Peak transaortic flow velocity≥ 4.0 m/sMeasures instantaneous velocityFlow-dependent
Best predictor of adverse eventsRequires correct alignment of Doppler signal with the flow direction
Ratio between peak transaortic flow velocity and peak LVOT velocity≤ 1/4Good reproducibility (compared with AVA calculation)Limited data on prognostic utility
Table 2 Indication for aortic valve replacement according to European Society of Cardiology/European Association for Cardio-Thoracic Surgery and American Heart Association/American College of Cardiology guidelines[33,34]
CriteriaLevel of recommendation
Differences between guidelines
ESC/EACTSAHA/ACC
Severe AS with any symptoms clearly due to AS, based on history or unmasked by stress testII"High-gradient" in AHA/ACC guidelines
Asymptomatic severe AS with LVEF < 50%II
Severe AS and another indication for surgery (CABG, thoracic aorta, another valve)II
Asymptomatic severe AS where the systolic blood pressure does not increase by > 20 mmHg or drops compared with baseline during the treadmill testIIaIIaAHA/ACC guidelines acknowledge the presence of fatigability during stress test as an indication for AVR
Moderate AS and another indication for surgery (CABG, thoracic aorta, another valve)IIaIIa
Low-flow/low-gradient/low-LVEF severe AS with proof of contractile reserve presenceIIaIIa
Symptomatic low-flow/low-gradient/preserved LVEF severe AS after careful confirmation of severityIIaIIa
Truly asymptomatic severe AS (no symptoms during treadmill test, no risk criteria) with preserved LVEF if the surgical risk is deemed low and the following criteria are also satisfied: Very severe AS (maximal velocity ≥ 5.5 m/s); Severe valvular calcification and increased maximal velocity by ≥ 0.3 m/s per yearIIaIIa for velocity ≥ 5 m/s (see text)AHA/ACC guideline: Velocity ≥ 5 m/s or mean gradient ≥ 60 mmHg AND severe calcifications; velocity 4 to 4.9 m/s or mean gradient 40 to 59 mmHg AND severe valvular calcification AND stress test demonstrating reduced tolerance or drop in blood pressure
IIb for maximal velocity increase by ≥ 0.3 m/s per year
Truly asymptomatic severe AS (no symptoms during treadmill test, no risk criteria) with preserved LVEF if the surgical risk is deemed low and 1 or more of the following criteria are also satisfied: Severely increased BNP/Nt-ProBNP levels at serial determinations and without an alternative explanation; increased transaortic pressure gradient at stress echocardiography by > 20 mmHg; excessive LV hypertrophy without an alternative explanationIIb-This indication is not covered in the AHA/ACC guidelines
Low-flow/low-gradient/low-LVEF severe AS without contractile/flow reserveIIb-This indication is not covered in the AHA/ACC guidelines
Table 3 Suggested high-risk criteria in asymptomatic severe aortic stenosis
TestHigh risk criteria
ElectrocardiogramPresence of LV hypertrophy with secondary ST segment deviation ("LV strain")
Blood testsHighly increased BNP/Nt-ProBNP levels
Stress testUnmasked symptoms: Fatigability/dyspnea at < 75 W, syncope/near syncope; angina
Lack of increase in systolic blood pressure by > 20 mmHg (or decrease) with exercise
Inducible myocardial ischemia (ST segment depression ≥ 2 mm)
Severe ventricular arrhythmias (sustained VT, polymorphic VT, VF)
Conventional Doppler echocardiographyVery severe AS (AVA ≤ 0.6 cm; maximal velocity ≥ 5 m/s)
LVEF < 50%
Severe LV hypertrophy (≥ 15 mm)?
Reduced LV longitudinal strain
Zva ≥ 4.5 mmHg/mL per square meters
Dobutamine stress echocardiography (in low-flow, low-gradient, low LVEF)Lack of contractile reserve
Exercise echocardiography (ergometric bicycle) - any severe ASIncrease in transvalvular pressure gradient by > 20 mmHg during exercise
Inducible pulmonary hypertension during exercise (systolic pulmonary pressure ≥ 60 mmHg)
Documentation of valvular calcificationPresence of severe valvular calcifications: Qualitatively (radiology, conventional echocardiography); quantitatively (computed tomography): Calcium score ≥ 1651 Agatston units (lower in women vs men)
Table 4 Criteria for the diagnosis of severe aortic regurgitation
Mild ARModerate ARSevere AR
Ratio between the AR jet diameter and the LVOT diameter< 25%25%-64%≥ 65%
Vena contracta (mm)< 33-5.9≥ 6
Regurgitant volume (mL/beat)< 3030-59≥ 60
Regurgitant fraction< 30%30%-49%≥ 50%
EROA (cm2)< 0.10.1-0.29 ≥ 0.3
Diastolic backflow in the descending thoracic and/or abdominal aortaMinimalLess than holodiastolicHolodiastolic (especially for backflow documented in the abdominal aorta)
Angiographic1+2+3-4+
LV dilatationNoNoYes (mandatory for chronic severe AR)
Table 5 Indications for aortic valve replacement in chronic aortic regurgitation[33,34]
CriteriaClass of indication
Differences between guidelines
ESC/EACTSAHA/ACC
Symptomatic severe AR (any LVEF)II
Asymptomatic severe AR with depressed LV function (LVEF < 50%)II
Severe AR in patients with another indication for cardiac surgery (e.g., CABG, thoracic aorta, another valve)II
Asymptomatic severe AR with normal LVEF (> 50%) but with severe LV dilatationIIaIIaDefinition of severe LV dilatation: ESC/EACTS guideline: End-diastolic LV diameter > 70 mm, or end-systolic LV diameter > 50 mm (or > 25 mm/m2); AHA/ACC guidelines: End-systolic LV diameter > 50 mm
Moderate AR in patients with another indication for cardiac surgery (e.g., coronary bypass, thoracic aorta, another valve)-IIaThis indication is not covered in the ESC/EACTS guidelines
Severe AR with normal LVEF (> 50%) but with progressive LV dilatation (end-diastolic LV diameter > 65 mm) if the surgical risk is low-IIbThis indication is not covered in the ESC/EACTS guidelines
Table 6 Indication for surgery in patients with bicuspid aortic valve and aortic root disease[33,34,66,67]
Class of indicationGuideline
Differences between guidelines
ESC/ EACTS 2012AHA/ACC 2016 Consensus on AHA/ACC 2014, and ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM 2010 Guidelines
I-Asymptomatic bicuspid aortic valve with dilatation of Valsalva sinuses or the ascending thoracic aortic diameter > 55 mmNo class I indications in the 2012 ESC/EACTS guidelines
IIaBicuspid aortic valve with an ascending thoracic aortic diameter > 50 mm if the patient also has at least one of the followings: Family history of aortic dissection; documented increase in the aortic diameter > 2 mm/yr (assessed using the same imaging method, at the same level, and with comparative images available); arterial hypertension; coarctation of the aortaBicuspid aortic valve AND dilatation of the Valsalva sinuses or of the ascending thoracic aorta (> 50 mm) AND at least one of the following
Family history of aortic dissection
Documented increase in aortic diameter > 5 mm/yr
OR low surgical risk in an expert center
-Replacement of the ascending aorta if the patient also has an indication for surgery for AS/AR, and the ascending aortic/Valsalva sinus diameter is > 45 mmNot covered by the 2012 ESC guidelines